Prospective Randomized Trial Between Two Doses of Granulocyte Colony-Stimulating Factor After Ifosfamide, Carboplatin, and Etoposide in Children With Recurrent or Refractory Solid Tumors: A Children's Cancer Group ReportMitchell S. Cairo, Gregory H. Reaman, Mark Krailo et al.|The American journal of pediatric hematology/oncology|2001Cited by 56